Investigation of Gait, Foot Pressure Distribution and Balance in Parkinson's Patients With Motor Freezing

NCT05107531 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-02-22

No results posted yet for this study

Summary

Parkinson's disease is characterized by cardinal motor signs such as bradykinesia, tremor, rigidity and postural instability. In addition to these findings, motor freezing, gait disorders, posture disorders, decreased arm swings and loss of axial rotation are also seen. About 80% of the causes of falls in Parkinson's patients are due to postural instability and motor freezing, and patients' quality of life is significantly affected. In addition, gait disorders are common in advanced stages of Parkinson's Disease. Gait disorders decrease the quality of life by increasing the risk of falls, fractures and mortality. Therefore, the aim of this study is to observe the change in gait, foot pressure distribution and balance parameters of Parkinson's patients with and without motor deceleration compared to each other and healthy controls and to determine the relationship between these parameters.

Conditions

  • Idiopathic Parkinson's Disease

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Kadriye Armutlu, Prof. Dr. · Hacettepe University

  • Süleyman Korkusuz, MSc · Hacettepe University

  • Emine Nur Demircan, MSc · Hacettepe University

  • Ayşenur Özcan, MSc · Hacettepe University

  • Büşra Seçkinoğulları, MSc · Hacettepe University

  • Gül Yalçın Çakmaklı, Assoc. Prof. · Hacettepe University

  • Bülent Elibol, Prof. Dr. · Hacettepe University

  • Ferdi Yavuz, Assoc. Prof.

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-10
Primary Completion
2022-02-05
Completion
2022-02-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05107531 on ClinicalTrials.gov